Ligand Pharm (LGND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Sales | 48,110 | 40,895 | 17,670 | 51,690 | 36,842 |
| Cost of Goods | 8,591 | 10,489 | 0 | 0 | 0 |
| Gross Profit | 39,519 | 30,406 | 17,670 | 51,690 | 36,842 |
| Operating Expenses | 85,992 | 92,188 | 87,290 | 82,520 | 69,699 |
| Operating Income | -45,882 | -61,293 | -69,620 | -30,830 | -32,857 |
| Interest Expense | 13,119 | 12,979 | 8,320 | 8,080 | 8,160 |
| Other Income | -276 | -447 | -39,940 | -61,240 | 3,704 |
| Pre-tax Income | -59,277 | -74,719 | -117,880 | -100,150 | -37,313 |
| Net Income Continuous | -59,277 | -74,719 | -74,927 | -35,180 | -32,857 |
| Net Income | $-72,376 | $-74,719 | $-117,880 | $-100,150 | $-37,313 |
| EPS Basic Total Ops | -7.80 | -9.48 | -17.52 | -18.12 | -7.80 |
| EPS Basic Continuous Ops | -6.36 | -9.48 | -11.13 | -6.37 | -6.85 |
| EPS Diluted Total Ops | -7.80 | -9.48 | -17.52 | -18.12 | -7.80 |
| EPS Diluted Continuous Ops | -6.36 | -9.48 | -11.13 | -6.37 | -6.85 |
| EBITDA(a) | $-30,425 | $-46,307 | $-65,110 | $-23,700 | $-26,175 |